Promatix Biosciences
PrivateLast Round
Series A
Apr 6, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Promatix Biosciences operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in March 2021.
Promatix Biosciences is a biotechnology company that develops next-generation bispecific antibody-drug conjugates for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promatix Biosciences Comparables
Compare Promatix Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthetic Design Lab | 86% | |
| Neok Bio | 81% | |
| Adcentrx Therapeutics | 81% |
For institutional investors. Book with your work email.
Promatix Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 6, 2026 | ||||
| Seed | Mar 8, 2021 |
For institutional investors. Book with your work email.
Promatix Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ALSA Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Completed a Series A funding round.
- Jan 8, 2026
Grew 30% QoQ, from 10 to 13 employees.
For institutional investors. Book with your work email.
Promatix Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Promatix Biosciences's valuation, stock price, and market status.
Is Promatix Biosciences a public or private company?
Promatix Biosciences is a private company.
What is the current stock price of Promatix Biosciences?
Promatix Biosciences is a private company, so its shares have no public market price. Caplight tracks Promatix Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Promatix Biosciences worth (valuation)?
Valuation information for Promatix Biosciences is not publicly available.
Can I buy Promatix Biosciences stock?
Promatix Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Promatix Biosciences's last funding round?
Promatix Biosciences's most recent funding round was Series A on April 6, 2026.
Who are the main investors in Promatix Biosciences?
Key investors in Promatix Biosciences include ALSA Ventures.
Will Promatix Biosciences IPO soon?
No public IPO plans have been announced for Promatix Biosciences.
How can I track Promatix Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Promatix Biosciences's shares on secondary markets.